Mallinckrodt public limited company chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 31.63
Dividend & YieldN/A$ (N/A)
Beta N/A
Market capitalization 119.99M
Operating cash flow -574M
ESG Scores unknown

Company description

Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, pulmonology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes; and gastrointestinal products. It offers Acthar Gel, a repository corticotropin injection for rheumatoid arthritis, infantile spasms, systemic lupus erythematosus, multiple sclerosis, systemic dermatomyositis, symptomatic sarcoidosis, severe acute and chronic allergic, and inflammatory diseases; INOmax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Therakos photopheresis, an immunotherapy treatment platform; Amitiza for constipation; and StrataGraft for the treatment of adults with deep partial-thickness burns. The company is also developing Terlipressin for the treatment of hepatorenal syndrome; and SLN 501 is a ribonucleic acid silencing therap. In addition, it provides specialty generic drugs and active pharmaceutical ingredients. The company markets its branded products to physicians, respiratory therapists, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. Mallinckrodt plc has collaboration with Silence Therapeutics plc to develop and commercialize ribonucleic acid interference drug targets. The company was founded in 1867 and is based in Dublin, Ireland.

Sector: Healthcare - Industry: Drug Manufacturers—Specialty & Generic

Financial data

Financial Statements

Cashflow Statement 2018-12-28 2019-12-27 2020-12-25 2021-12-31
Change To Liabilities 24.6M 6.7M 15.7M -1.1M
Total Cashflows From Investing Activities -480.3M -8.3M -11.2M -37.8M
Net Borrowings -1B -250.1M -139.5M -137.5M
Total Cash From Financing Activities -1.09B -280.1M -185.6M -137.5M
Change To Operating Activities 5.5M 1.44B 543.6M 178.5M
Issuance Of Stock 1M 600k
Net Income -3.61B -996.5M -944.6M -717.4M
Change In Cash -911.6M 455.1M 304.4M 278.2M
Effect Of Exchange Rate -1.8M 600k 2.3M -1.9M
Total Cash From Operating Activities 665.5M 742.9M 498.9M 455.4M
Depreciation 846.9M 951.1M 872.9M 673.7M
Change To Account Receivables -145.8M 31.6M 37.9M 98.2M
Other Cashflows From Financing Activities -35.2M -28M -45.7M
Change To Netincome 3.38B -663.3M 458.3M 129M
Capital Expenditures -127M -133M -47.7M -55.3M

Income Statement 2018-12-28 2019-12-27 2020-12-25 2021-12-31
Research Development 361.1M 349.4M 290.8M 205.2M
Income Before Tax -4.05B -1.59B -960.8M -829.8M
Net Income -3.61B -996.5M -944.6M -717.4M
Selling General Administrative 878.4M 828.2M 768.9M 571.2M
Gross Profit 1.6B 1.42B 669.4M 891.7M
Ebit 357.7M 243.8M -390.3M 115.3M
Operating Income 357.7M 243.8M -390.3M 115.3M
Interest Expense -370.2M -309M -261.1M -222.6M
Income Tax Expense -430.1M -584.3M 8.9M -106.3M
Total Revenue 3.22B 3.16B 2.21B 2.21B
Cost Of Revenue 1.62B 1.74B 1.54B 1.32B
Total Other Income ExpenseNet -4.41B -1.84B -570.5M -945.1M
Net Income From Continuing Ops -3.62B -1.01B -969.7M -723.5M
Net Income Applicable To Common Shares -3.61B -996.5M -944.6M -717.4M

Balance Sheet Statement 2018-12-28 2019-12-27 2020-12-25 2021-12-31
Total Liabilities 7.99B 8.4B 8.7B 8.6B
Total Stockholder Equity 2.89B 1.94B 1.02B 313.4M
Other Current Liabilities 117.4M 54.8M 30.2M 12.6M
Total Assets 10.88B 10.34B 9.72B 8.92B
Common Stock 18.5M 18.7M 18.8M 18.9M
Other Current Assets 20.2M 24M
Retained Earnings -1.02B -2.02B -2.96B -3.68B
Treasury Stock -1.64B -1.62B -1.63B -1.62B
Cash 348.9M 790.9M 1.07B 1.34B
Total Current Liabilities 943.7M 1.43B 4.12B 1.94B
Other Stockholder Equity -24.3M -7.9M -9.6M -8.3M
Property, Plant, and Equipment 982M 980M 891.7M 811M
Total Current Assets 1.43B 1.83B 2.3B 2.31B
Net Tangible Assets -5.4B -5.08B -5.17B -5.13B
Net Receivables 639.5M 585.5M 727.5M 475.6M
Accounts Payable 147.5M 139.8M 93.3M 123M


Insider Transactions

Here are the insider transactions of stock shares related to Mallinckrodt public limited company:

Filer Name Transaction Text Ownership Date Filer Relation Shares
RICHARDSON PETER CStock Award(Grant) at price 0.00 per share.D2023-02-02Officer75.09k
BISARO PAUL M.Stock Award(Grant) at price 0.00 per share.D2023-01-03Director39.08k
SULAT JAMES RStock Award(Grant) at price 0.00 per share.D2023-01-03Director26.28k
MYERS WOODROW A JRStock Award(Grant) at price 0.00 per share.D2023-01-03Director26.28k
GOLDMAN NEAL PStock Award(Grant) at price 0.00 per share.D2023-01-03Director26.28k
LING KARENStock Award(Grant) at price 0.00 per share.D2023-01-03Director26.28k
SILBERMANN SUSAN MICHELEStock Award(Grant) at price 0.00 per share.D2023-01-03Director26.28k
CELENTANO DANIEL ARTHURStock Award(Grant) at price 0.00 per share.D2023-01-03Director26.28k
EL-DADA RIAD HUSSEINStock Award(Grant) at price 0.00 per share.D2023-01-03Director26.28k
OLAFSSON SIGURDUR OStock Award(Grant) at price 0.00 per share.D2022-12-14Chief Executive Officer225.27k
REASONS BRYAN MStock Award(Grant) at price 0.00 per share.D2022-12-14Chief Financial Officer112.64k
HARROLD KASSIEStock Award(Grant) at price 0.00 per share.D2022-12-14Officer37.55k
GOODSON JASON DANIELStock Award(Grant) at price 0.00 per share.D2022-12-14Officer37.55k
NIELSEN HENRIETTEStock Award(Grant) at price 0.00 per share.D2022-12-14Officer75.09k
WELCH STEPHEN ANDREWStock Award(Grant) at price 0.00 per share.D2022-12-14Officer37.55k
TYNDALL MARK ANTHONYStock Award(Grant) at price 0.00 per share.D2022-12-14Officer75.09k
FRENCH LISAStock Award(Grant) at price 0.00 per share.D2022-12-14Officer75.09k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Mallinckrodt public limited company. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Mallinckrodt public limited company

Here is the result of two systematic investment strategies applied to Mallinckrodt public limited company. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Mallinckrodt public limited company

The following chart shows the equity curve of the two systematic investment strategies applied to Mallinckrodt public limited company:

Mallinckrodt public limited company automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -57.88% on the backtest period.

Performance at glance

Performance

-57.88 %

Latent gain

-1304.86 $

Invested capital

2254.3 $

Annualized return

-13.98 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Mallinckrodt public limited company

This is the result of two momentum investment strategies applied to Mallinckrodt public limited company. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Mallinckrodt public limited company

The following chart shows all the entries opened by the momentum investment system on Mallinckrodt public limited company:

Mallinckrodt public limited company momentum entries
  • The first momentum investment strategy would give -56.84% of return on Mallinckrodt public limited company. That represents -2268.67$ of latent gain with 3991.37$ of employed capital.
  • The second momentum investment strategy would give -69.08% of return on Mallinckrodt public limited company. That represents -2571.9$ of latent gain with 3723.28$ of employed capital.
Performance at glance (1Q Momentum)

Performance

-56.84 %

Latent gain

-2268.67 $

Invested capital

3991.37 $

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

-69.08 %

Latent gain

-2571.9 $

Invested capital

3723.28 $

Annualized return

-18.87 %

Momentum equity curve on Mallinckrodt public limited company

The following chart shows the equity curve of the two momentum strategies applied to Mallinckrodt public limited company:

Mallinckrodt public limited company momentum equity

Note: the dividends potentially given by Mallinckrodt public limited company are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Mallinckrodt public limited company

The following chart shows the employed capital evolution of the two momentum strategies on Mallinckrodt public limited company since the beginning:

Mallinckrodt public limited company

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Mallinckrodt public limited company

Buy the dip entry openings on Mallinckrodt public limited company

Mallinckrodt public limited company

The performance achieved by the robo-advisor on Mallinckrodt public limited company is 0%. That represents 0.0$ of latent gain with 0.0$ of employed capital. The following chart shows Mallinckrodt public limited company stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Mallinckrodt public limited company, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

0.0 %

Equity curve of the strategy applied to Mallinckrodt public limited company

The following chart shows the result of the investment strategy applied to Mallinckrodt public limited company:

Mallinckrodt public limited company

Note: the dividends potentially given by Mallinckrodt public limited company are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Mallinckrodt public limited company

The following chart shows the employed capital evolution since the beginning of the investment strategy on Mallinckrodt public limited company:

Mallinckrodt public limited company

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Mallinckrodt public limited company

In this section, I will compare the three previous investment strategies applied to Mallinckrodt public limited company.

Equity curve comparison on Mallinckrodt public limited company

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Mallinckrodt public limited company investment strategy comparison

Employed capital comparison on Mallinckrodt public limited company

Mallinckrodt public limited company investment comparison

Performance comparison on Mallinckrodt public limited company

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -57.88% -1304.86$ 2254.3$ -13.98%
Momentum 1 quarter -56.84% -2268.67$ 3991.37$ -14.57%
Momentum 2 quarters -69.08% -2571.9$ 3723.28$ -18.87%
Non-directional 0% 0.0$ 0.0$ 0.0%
Annualized return comparison

Automatic investment

-13.98 %

Momentum 1Q

-18.87 %

Momentum 2Q

-18.87 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Mallinckrodt public limited company:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Mallinckrodt public limited company and the other stocks. There may be false positives or some missing correlated stocks. If the price of Mallinckrodt public limited company does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Mallinckrodt public limited company
Country Ireland
City Dublin
Address College Business & Technology Park
Phone 353 1 696 0000
Website www.mallinckrodt.com
FullTime employees 2778
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
Exchange XNYS
Ticker MNK
Market www.nyse.com

Mallinckrodt public limited company ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown